U.S. market Closed. Opens in 3 hours 13 minutes

MLYS | Mineralys Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/A
Operating Expenses84.66M31.48M18.73M2.94M
Selling, General & Admin14.30M5.23M2.42M532.00K
Research & Development70.36M26.25M16.31M2.41M
Other Operating ExpensesN/A4.00K1.00K-1.00K
Operating Income-84.66M-31.48M-18.73M-2.94M
Other Expenses / Income12.76M4.00K-656.00K-368.00K
Before Tax Income-71.90M-29.80M-19.41M-3.43M
Income Tax Expenses-167.90K-1.90M27.00K115.00K
Net Income-71.90M-29.80M-19.41M-3.43M
Interest ExpensesN/A1.68M27.00K115.00K
Basic Shares Outstanding36.19M40.86M39.06M39.06M
Diluted Shares Outstanding36.19M40.86M39.06M39.06M
EBITDA-84.66M-31.48M-18.72M-2.94M
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-72.07M-30.03M-19.35M-3.20M
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙